Deal Maker of the Year Awards 2012 WINNER - GERMANY
DEAL: Roche to Acquire Germany- based Verum Diagnostica
NAME: Thomas Welte COMPANY: Autaco GmbH POSITION: Senior Partner, CPA & Tax Accountant ADDRESS: AUTACO GmbH, Kardinal-Faulhaber-Strasse 15 80333 Munchen, Germany
TEL: +49 (0)89 20 400 77-0 EMAIL:
kontakt@autaco.de WEBSITE:
www.autaco.de
DEAL OVERVIEW:
In the acquisition of Verum Diagnostica by the Roche Group, we were advising Dynabyte GmbH, as the owner of Verum. From the very beginning of the M&A process we consulted Dynabyte in respect to different options of the process and the financial and tax implications. During the actual negotiations and contracting process we supported the seller in developing a mutually agreeable and workable purchase price adjustment mechanism.
Under the terms of the acquisition agreement, Roche paid Verum Diagnostica shareholders a total cash consideration of eleven million euros, and will pay potentially a further two million euros
BIO:
Thomas Welte, Certified Public Accountant and Tax Consultant, began his career with the Finance Ministry of Baden-Württemberg in Stuttgart upon completion of his business studies, earning the degree of Diplom- Finanzwirt. He then moved to KPMG Peat Marwick Treuhand GmbH/KPMG Deutsche Treuhand-Gesellschaft AG, where he rose to the level of partner. His areas of responsibility focused on corporate reorganizations (including M&A), development of innovative investment and financing models, and provision of tax and management consulting services for non-profit organizations.
After his time at KPMG, Thomas Welte 76
www.finance-monthly.com
established the corporate tax department of Taurus Holding GmbH & Co. KG, Munich as Senior Vice President Group Accounting & Taxes, and was responsible for the strategic planning, management, and organization of corporate and shareholding structures. He also assumed operational direction of individual companies of the corporate group, including the Formula 1 Group company in Jersey and London, UK.
He then founded Autaco GmbH in Munich and concentrated his efforts on providing consulting and advisory services to large and medium-sized enterprises, particularly with regard to corporate tax issues involved in
corporate acquisitions, reorganizations and restructing, and insolvencies, as well as the development of innovative investment and financing models for private industry and public authorities.
Thomas Welte is the initiator of the AG Medienerlass (Media Law Working Group) of the Film, TV, and Fund Industry, a member of the Financial Times’ TMA Society for Restructuring, associate at ICPAS Institute of Certified Public Accountants Singapore. He is also the author of numerous specialized publications in the professional literature.
contingent upon reaching certain performance-related milestones. The transaction closed in January 2012.
With the acquisition of Verum Diagnostica, a leading company in coagulation diagnostics, Roche has secured Verum Diagnostica’s Multiplate® system. Multiplate® allows the rapid and sensitive analysis of platelet function, which is highly relevant for patients with heart attacks, stent placements, as well as patients undergoing surgical procedures. Headquartered in Basel, Switzerland, Roche is the world leader in in-vitro diagnostics.
Thomas Welte, Senior Partner Autaco: We
were in touch with Dynabyte from the very beginning of the Multiplate project in 2003 and supported the company in various projects, where we could offer our expertise. We were excited to support the company grow through various phases, finally leading to the acquisition by the world leader in the diagnostics segment.
Dr. Andreas Calatzis, CEO of Dynabyte: Autaco made an outstanding job. Their recommendations helped us a lot in the process and their predictions and estimations turned out very accurate. It was the first deal of this kind for our team. Autaco´s expertise and support was indispensible for its success.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126